212 related articles for article (PubMed ID: 2106449)
1. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome.
Larsen T; Larsen JF; Schiøler V; Bostofte E; Felding C
Fertil Steril; 1990 Mar; 53(3):426-31. PubMed ID: 2106449
[TBL] [Abstract][Full Text] [Related]
2. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
van Weissenbruch MM; Schoemaker HC; Drexhage HA; Schoemaker J
Hum Reprod; 1993 Jun; 8(6):813-21. PubMed ID: 8345068
[TBL] [Abstract][Full Text] [Related]
3. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
[TBL] [Abstract][Full Text] [Related]
4. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
Sagle MA; Hamilton-Fairley D; Kiddy DS; Franks S
Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
[TBL] [Abstract][Full Text] [Related]
5. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
Venturoli S; Orsini LF; Paradisi R; Fabbri R; Porcu E; Magrini O; Flamigni C
Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
[TBL] [Abstract][Full Text] [Related]
7. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
8. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
9. Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.
Turkmen S; Backstrom T; Idil M
Gynecol Endocrinol; 2004 Aug; 19(2):69-78. PubMed ID: 15624268
[TBL] [Abstract][Full Text] [Related]
10. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin.
Seibel MM; McArdle C; Smith D; Taymor ML
Fertil Steril; 1985 May; 43(5):703-8. PubMed ID: 3922800
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.
Couzinet B; Lestrat N; Brailly S; Forest M; Schaison G
J Clin Endocrinol Metab; 1988 Mar; 66(3):552-6. PubMed ID: 3127417
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.
Balasch J; Fábregues F; Casamitjana R; Peñarrubia J; Vanrell JA
Reprod Biomed Online; 2003; 6(3):296-301. PubMed ID: 12735863
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
Farhi J; Jacobs HS
Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
[TBL] [Abstract][Full Text] [Related]
14. A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome.
Anderson RE; Cragun JM; Chang RJ; Stanczyk FZ; Lobo RA
Fertil Steril; 1989 Aug; 52(2):216-20. PubMed ID: 2502437
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
Uemura T; Yoshimura Y; Ishikawa M; Asukai K; Minaguchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):923-6. PubMed ID: 2507714
[No Abstract] [Full Text] [Related]
16. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian response and induction of ovulation with human menopausal gonadotropin of different ratio of FSH to LH content in women with ovarian insufficiency].
Koyama T; Kamata S; Kubota T; Ohara M; Ichimura M; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):445-51. PubMed ID: 3131463
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
19. The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.
Mizunuma H; Takagi T; Yamada K; Andoh K; Ibuki Y; Igarashi M
Fertil Steril; 1991 Jan; 55(1):66-72. PubMed ID: 1898893
[TBL] [Abstract][Full Text] [Related]
20. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
Hamori M; Zwirner M; Clédon P; Tinneberg HR
Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
